Drug combo cuts risk of death in advanced prostate cancer by 40%, clinical trial finds

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Prostate Cancer: Drug Combo Lowers Death Risk by 40% in Aggressive Cases

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Novartis' Pluvicto shown to reduce risk of progression or death by 28% in prostate cancer

Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death ...
Science Daily

This powerful drug combo cuts prostate cancer deaths by 40%

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
Yahoo

What’s Going Around: Non-invasive prostate cancer treatment

WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer in ...
Medscape

Deaths From Prostate Cancer vs Other Causes: Long-Term Data on NCCN-Based Care

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.
Orlando Sentinel

Editorial: Ivermectin rides again — this time in Florida’s cancer fund

Florida is poised to become ivermectin’s new best friend. Thanks to conspiracy theory-spouting social media influencers, the go-to treatment for horse worms and small-animal mange has leapt from ...